查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
临床肿瘤学下一代定序市场，按工作流程类型、技术、按应用、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1364700

临床肿瘤学下一代定序市场，按工作流程类型、技术、按应用、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Clinical Oncology Next Generation Sequencing Market, By Workflow Type, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年临床肿瘤学次世代定序市场规模为 3.884 亿美元，2023 年至 2030 年复合年增长率为 16.5%。

临床肿瘤学次世代定序市场-市场动态

癌症盛行率的上升预计将推动临床肿瘤学下一代定序市场的成长。

随着癌症盛行率的上升，人们更需要更好地了解这种疾病并发现新的药物。次世代定序（NGS）检测正迅速成为晚期癌症患者治疗的首选。 NGS 检测使用高通量 DNA 定序技术对完整基因组、完整外显子组或某些基因外显子（标靶组）进行定序。 2020年美国报告新增癌症病例1,603,844例，602,347人死于癌症。每10万人中，新增癌症病例403例，144人死于癌症。根据疾病管制与预防中心的数据，2020 年是可取得发病率资料的最新一年。此外，次世代定序开启了新的肿瘤学研究发现的大门，这可能会揭示新的癌症进展途径和过程。它为市场提供了成长机会。然而，NGS 技术和基础设施所需的初始投资成本高昂，可能会限制市场成长，

临床肿瘤学下一代定序市场 - 关键见解

  • 根据我们的研究分析师分享的分析，全球临床肿瘤下一代定序市场预计在预测期（2023-2030 年）每年将以 16.5% 左右的复合年增长率成长
  • 由于技术进步和研究支出的增加，预计临床肿瘤学下一代定序市场将迅速扩大。
  • 根据工作流程细分，NGS 定序预计将在 2022 年显示最大的市场份额
  • 从技术细分来看，标靶定序、重定序是2022年的主导类型
  • 从应用细分来看，2022年筛选为主导类型
  • 根据最终用户细分，筛选是 2022 年的主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

临床肿瘤学次世代定序市场細項分析：

全球临床肿瘤学下一代定序市场根据工作流程类型、应用、技术、最终用户和地区进行细分。

根据工作流程，市场分为三类： NGS预测序、NGS定序和NGS资料分析。 NGS 定序领域主导市场。 NGS 是指目前的一类定序技术，与旧方法相比，它可以实现更快、更便宜的 DNA 和 RNA 定序。这些技术能够同时对数百万至数十亿个 DNA 分子进行定序。

根据技术，市场分为三类：全基因组定序、全外显子定序以及标靶定序和重定序。靶向测序和重测序领域主导着市场成长。标靶定序不是对整个基因组进行定序，而是重点关注与疾病相关或怀疑与疾病相关的某些基因或感兴趣的区域。对先前定序的 DNA 进行定序称为重定序。目的是找到变体，特别是在感兴趣的领域。

根据应用，市场分为两类：筛检、伴随诊断和其他诊断。放映产业在市场中占据主导地位，并可能在预测期内保持其主导地位。肿瘤和种系 DNA 的下一代定序 (NGS) 是精准肿瘤学的基础，具有迅速扩展的诊断、预后和治疗意义。 NGS 在肿瘤诊断和筛检技术中的使用导致了市场的显着扩张。对 NGS 面板、设备和相关服务的需求急剧增加。

根据最终用户，市场分为三类：医院、诊所和实验室。实验室主导市场。许多诊断实验室已经实施了NGS平台来提供肿瘤基因组分析，帮助医生识别可操作的突变并相应地定製药物。

临床肿瘤学次世代定序市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。由于研发投资的增加以及癌症负担的增加，预计北美将主导临床肿瘤学下一代定序市场的成长。北美癌症发生率的增加需要新的诊断和治疗方案。美国在医疗和生物技术研究方面投入大量资金。

公共和商业部门每年在研发上投资数十亿美元，推动新技术的改进和接受。美国国家科学基金会国家科学与工程统计中心 (NCSES) 的最新资料显示，2020 年美国的研究与实验开发 (R&D) 总额达 7170 亿美元。欧洲预计将成为第二大市场由于新医疗技术的日益普及，临床肿瘤学一代定序。

临床肿瘤学次世代定序市场-竞争格局：

下一代定序（NGS）技术的市场已大幅扩大。医疗保健领域的决策者需要了解市场成长和未来趋势的事实知识，以便设计合适的策略和法规，但对这些模式的性质和规模知之甚少。公司经常透过合作或合併来提升自己的地位。主要公司正在将业务扩展到亚洲、拉丁美洲和非洲的新兴国家，这些国家对现代医疗技术的需求不断增长。此外，许多新创公司带来了新的技术或方法，这可能会提供更快的定序、更高的准确性或更低的价格。例如，2022 年4 月12 日，Thermo Fisher Scientific 最近推出了带有CE-IVD 标誌的Ion Torrent Genexus Dx 整合定序仪，这是一种自动化的下一代定序(NGS) 平台，可在一天内提供结果。

最近的发展：

2021 年 12 月，罗氏宣布推出 AVENIO Edge System，这是罗氏推进定序技术策略的核心组成部分。以一流的基础功能为基础，提供完全自动化的整合定序解决方案。罗氏致力于开发诊断解决方案，旨在为医疗保健界提供更快、更准确的医疗讯息，以预测风险和检测疾病。

目录

第 1 章：临床肿瘤学下一代定序市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按工作流程类型分類的临床肿瘤学下一代定序市场片段
    • 临床肿瘤学次世代定序市场片段（按技术）
    • 临床肿瘤学次世代定序市场片段（按应用）
    • 最终用户的临床肿瘤学下一代定序市场片段
    • 按国家/地区分類的临床肿瘤学下一代定序市场片段
    • 按地区分類的临床肿瘤学下一代定序市场片段
  • 竞争洞察

第 3 章：临床肿瘤学下一代定序主要市场趋势

  • 临床肿瘤学次世代定序市场驱动因素
    • 市场驱动因素的影响分析
  • 临床肿瘤学次世代定序市场限制
    • 市场限制影响分析
  • 临床肿瘤学次世代定序市场机会
  • 临床肿瘤学次世代定序市场未来趋势

第 4 章：临床肿瘤学下一代定序产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：临床肿瘤学下一代定序市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：临床肿瘤学下一代定序市场格局

  • 2022 年临床肿瘤学下一代定序市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：临床肿瘤学下一代定序市场 - 按工作流程类型

  • 概述
    • 按工作流程类型分類的细分市场占有率分析
    • NGS预测序
    • NGS定序
    • NGS数据分析

第 8 章：临床肿瘤学下一代定序市场 - 按技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • 全基因组定序
    • 全外显子定序
    • 标靶定序和重定序

第 9 章：临床肿瘤学下一代定序市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 筛选
      • 散发性癌症
      • 遗传性癌症
    • 伴随诊断
    • 其他诊断

第 10 章：临床肿瘤学下一代定序市场 - 按最终用户

  • 概述
    • 按技术分類的细分市场份额分析
    • 医院
    • 诊所
    • 实验室

第 11 章：临床肿瘤学下一代定序市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 临床肿瘤学下一代定序北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按工作流程类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲临床肿瘤学下一代定序主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按工作流程类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区临床肿瘤下一代定序主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依工作流程类型）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲临床肿瘤学下一代定序主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按工作流程类型）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 临床肿瘤学下一代定序中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按工作流程类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：关键供应商分析 - 临床肿瘤学下一代定序产业

  • 竞争仪表板
  • 公司简介
    • Illumina, Inc.
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche Ltd.
    • Agilent Technologies
    • Myriad Genetics
    • Foundation Medicine
    • Paradigm Diagnostics
    • Partek, Inc.
    • Pacific Bioscience
    • Qiagen NV
    • Beijing Genomics Institute (BGI)
    • Perkin Elmer
    • Oxford Nanopore Technologies Ltd.
    • Caris Life Sciences
    • Eurofins Scientific SE

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1748

REPORT HIGHLIGHT

Clinical Oncology Next Generation Sequencing Market size was valued at USD 388.4 Million in 2022, expanding at a CAGR of 16.5% from 2023 to 2030.

Next-generation sequencing (NGS), also known as massively parallel sequencing, is a powerful method for capturing a vast quantity of genomic information about a tumor. The majority of NGS technologies rely on synthesis-based sequencing. NGS has recently been used in clinical oncology to advance individualized cancer treatment. NGS is utilized to find familial cancer mutation carriers, identify novel and rare cancer mutations, and offer molecular rationale for effective targeted therapy. With targeted therapies becoming the new standard of care in oncology, NGS-driven companion diagnostics are generally expected to influence therapy selection to enhance patient outcomes.

Clinical Oncology Next Generation Sequencing Market- Market Dynamics

The rising prevalence of cancer is expected to drive the growth of the Clinical Oncology Next Generation Sequencing market.

As the prevalence of cancer rises, there is more need to better understand the disease and discover novel medicines. Next-generation sequencing (NGS) assays are quickly becoming the preferred option in the treatment of advanced cancer patients. NGS assays use high-throughput DNA sequencing technology to sequence the complete genome, the full exome, or certain gene exons (targeted panels). In the United States in 2020, 1,603,844 new cancer cases were reported and 602,347 people died of cancer. For every 100,000 people, 403 new cancer cases were reported and 144 people died of cancer. 2020 is the latest year for which incidence data are available, according to Centers for Disease Control and Prevention. Furthermore, Next Generation Sequencing opens the entrance to new oncological research discoveries, which may uncover new cancer progression pathways and processes. It provides growth opportunities for the market. However, the high cost of initial investment required for NGS technology and infrastructure can restrict market growth,

Clinical Oncology Next Generation Sequencing Market- Key Insights

  • As per the analysis shared by our research analyst, the global Clinical Oncology Next Generation Sequencing market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2023-2030)
  • The Clinical Oncology Next Generation Sequencing market is predicted to expand rapidly as a result of growing technological advancements and increased research spending.
  • Based on Workflow segmentation, NGS Sequencing was predicted to show maximum market share in the year 2022
  • Based on Technology segmentation, Targeted Sequencing, and resequencing were the leading type in 2022
  • Based on Application segmentation, Screening was the leading type in 2022
  • Based on End-User segmentation, Screening was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Clinical Oncology Next Generation Sequencing Market- Segmentation Analysis:

The Global Clinical Oncology Next Generation Sequencing Market is segmented on the basis of Workflow Type, Application, Technology, End-User, and Region.

The market is divided into three categories based on Workflow: NGS Pre-Sequencing, NGS Sequencing, and NGS Data Analysis. The NGS Sequencing segment dominates the market. NGS refers to a class of current sequencing technologies that enable significantly faster and less expensive DNA and RNA sequencing than older approaches. These technologies have the ability to sequence millions to billions of DNA molecules at the same time.

The market is divided into three categories based on Technology: Whole Genome Sequencing, Whole Exome Sequencing, and Targeted Sequencing and resequencing. Targeted Sequencing and resequencing segment dominates the market growth. Rather than sequencing the entire genome, targeted sequencing focuses on certain genes or regions of interest that have been linked to disease or are suspected to be linked to disease. The sequencing of previously sequenced DNA is referred to as resequencing. The purpose is to find variants, particularly in areas of interest.

The market is divided into two categories based on application: Screening, Companion Diagnostics, and other diagnostics. The Screening sector dominates the market and is likely to maintain its dominance during the forecast period. Next-generation sequencing (NGS) of tumor and germline DNA is foundational for precision oncology, with rapidly expanding diagnostic, prognostic, and therapeutic implications. The use of NGS in oncology diagnostic and screening techniques has resulted in significant market expansion. The need for NGS panels, equipment, and related services has increased dramatically.

The market is divided into three categories based on End-User: Hospitals, Clinics, and Laboratories. Laboratories dominate the market. Many diagnostic laboratories have implemented NGS platforms to provide tumor genomic profiling, assisting doctors in identifying actionable mutations and tailoring medicines accordingly.

Clinical Oncology Next Generation Sequencing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Clinical Oncology next-generation Sequencing market, due to increasing R&D investment, and the Rising Burden of Cancer. The increased incidence of cancer in North America needs novel diagnostic and treatment options. The United States invests much in medical and biotechnology research.

Both the public and commercial sectors invest billions of dollars in R&D each year, fueling improvements and the acceptance of new technology. New data from the National Center for Science and Engineering Statistics (NCSES) within the National Science Foundation indicate that research and experimental development (R&D) performed in the United States totaled USD 717.0 billion in 2020. Europe is expected to be the second-largest market for Clinical Oncology Generation Sequencing, due to increasing penetration of new medical technologies.

Clinical Oncology Next Generation Sequencing Market- Competitive Landscape:

The market for next-generation sequencing (NGS) technologies has expanded substantially. Decision-makers in health care require factual knowledge of market growth and future trends in order to design suitable strategies and regulations, yet little is known about the nature and magnitude of these patterns. Companies frequently collaborate or merge to boost their position. Major firms are expanding their presence into emerging countries in Asia, Latin America, and Africa, where there is a growing demand for modern medical technologies. Also, a number of startups bring fresh technology or approaches to the table, which may offer faster sequencing, higher accuracy, or lower prices. For example, On April 12, 2022, Thermo Fisher Scientific recently launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in one day.

Recent Developments:

In December 2021, Roche nowadays announced the launch of the AVENIO Edge System, a core component of Roche's strategy to advance sequencing technologies. Built on best-in-class foundational capabilities to deliver a fully automated, integrated sequencing solution. Roche is committed to developing diagnostic solutions with the goal of providing the healthcare community with faster and more accurate medical information to predict risk and detect disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET KEY PLAYERS

  • Illumina, Inc.
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies
  • Myriad Genetics
  • Foundation Medicine
  • Paradigm Diagnostics
  • Partek, Inc.
  • Pacific Bioscience
  • Qiagen N.V.
  • Beijing Genomics Institute (BGI)
  • Perkin Elmer
  • Oxford Nanopore Technologies Ltd.
  • Caris Life Sciences
  • Eurofins Scientific S.E.

GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY WORKFLOW TYPE

  • NGS Pre-Sequencing
  • NGS Sequencing
  • NGS Data Analysis

GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing

GLOBAL CLINICAL ONCOLOGY NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

  • Screening
  • Sporadic Cancer
  • Inherited Cancer
  • Companion Diagnostics
  • Other Diagnostics

GLOBAL CLINICAL ONCOLOGY NEXT-GENERATION SEQUENCING MARKET, BY END-USER

  • Hospitals
  • Clinics
  • Laboratories

GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Clinical Oncology Next Generation Sequencing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Oncology Next Generation Sequencing Market Snippet by Workflow Type
    • 2.1.2. Clinical Oncology Next Generation Sequencing Market Snippet by Technology
    • 2.1.3. Clinical Oncology Next Generation Sequencing Market Snippet by Application
    • 2.1.4. Clinical Oncology Next Generation Sequencing Market Snippet by End-User
    • 2.1.5. Clinical Oncology Next Generation Sequencing Market Snippet by Country
    • 2.1.6. Clinical Oncology Next Generation Sequencing Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Oncology Next Generation Sequencing Key Market Trends

  • 3.1. Clinical Oncology Next Generation Sequencing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Oncology Next Generation Sequencing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Oncology Next Generation Sequencing Market Opportunities
  • 3.4. Clinical Oncology Next Generation Sequencing Market Future Trends

4. Clinical Oncology Next Generation Sequencing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Oncology Next Generation Sequencing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Clinical Oncology Next Generation Sequencing Market Landscape

  • 6.1. Clinical Oncology Next Generation Sequencing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Oncology Next Generation Sequencing Market - By Workflow Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Workflow Type, 2022 & 2030 (%)
    • 7.1.2. NGS Pre-Sequencing
    • 7.1.3. NGS Sequencing
    • 7.1.4. NGS Data Analysis

8. Clinical Oncology Next Generation Sequencing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 8.1.2. Whole Genome Sequencing
    • 8.1.3. Whole Exome Sequencing
    • 8.1.4. Targeted Sequencing & Resequencing

9. Clinical Oncology Next Generation Sequencing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Screening
      • 9.1.2.1. Sporadic Cancer
      • 9.1.2.2. Inherited Cancer
    • 9.1.3. Companion Diagnostics
    • 9.1.4. Other Diagnostics

10. Clinical Oncology Next Generation Sequencing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Laboratories

11. Clinical Oncology Next Generation Sequencing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Clinical Oncology Next Generation Sequencing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Illumina, Inc.
    • 12.2.2. Thermo Fisher Scientific
    • 12.2.3. F. Hoffmann-La Roche Ltd.
    • 12.2.4. Agilent Technologies
    • 12.2.5. Myriad Genetics
    • 12.2.6. Foundation Medicine
    • 12.2.7. Paradigm Diagnostics
    • 12.2.8. Partek, Inc.
    • 12.2.9. Pacific Bioscience
    • 12.2.10. Qiagen N.V.
    • 12.2.11. Beijing Genomics Institute (BGI)
    • 12.2.12. Perkin Elmer
    • 12.2.13. Oxford Nanopore Technologies Ltd.
    • 12.2.14. Caris Life Sciences
    • 12.2.15. Eurofins Scientific S.E.

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Clinical Oncology Next Generation Sequencing Market: Workflow Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Workflow Type
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Workflow Type 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Technology 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Application 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by End-User 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Clinical Oncology Next Generation Sequencing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Workflow Type segment market share analysis, 2022 & 2030
  • FIGURE Workflow Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Europe Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Asia Pacific Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Latin America Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Middle East and Africa Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE Germany Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE India Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE Brazil Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)